Family-Based Treatment for Childhood Type 1 Diabetes and Obesity
(FBT for T1D Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Type 1 Diabetes carries high burden for affected youth and their families. Advances in insulin therapy and technology have been associated with increased obesity with 1/3 adolescents being overweight/obese. Since obesity runs in families and carries risk for poor outcomes psychologically and medically, the investigators are adapting our successful evidence-based Family Based Treatment for hybrid delivery to improve obesity and metabolic control in the affected youth and improve obesity and related co-morbidities in their parents.
Will I have to stop taking my current medications?
The trial requires that participants stop taking medications that can affect weight, such as those for Attention Deficit Disorder or high-dose steroids for asthma.
Is family-based treatment generally safe for children?
How is Family-Based Treatment for T1D different from other treatments for childhood Type 1 Diabetes and obesity?
Family-Based Treatment for T1D is unique because it involves the whole family in the treatment process, focusing on nutrition, physical activity, and behavior changes. This approach is different from standard treatments that often focus solely on the individual child, and it leverages the support and involvement of family members to improve outcomes.12678
What data supports the effectiveness of the treatment Family-Based Treatment for T1D in the clinical trial for childhood type 1 diabetes and obesity?
Research shows that family-based interventions can improve family relationships and communication, which are important for managing type 1 diabetes in children. Although the effects on treatment adherence and blood sugar control were not strong, these interventions can still support better overall health outcomes.910111213
Are You a Good Fit for This Trial?
This trial is for children aged 6-17 with Type 1 Diabetes (T1D) who are overweight/obese, use an insulin pump and continuous glucose monitoring device. They must have had T1D for at least a year and have one parent willing to join the program who is also overweight/obese. Excluded are those unable to do mild exercise, with certain chronic/autoimmune conditions or on weight-affecting meds.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Family-Based Behavioral Treatment with weekly coaching sessions for nine weeks, followed by bi-weekly sessions for two months, and then monthly sessions
Follow-up
Participants are monitored for changes in weight, HbA1c, insulin dosing, and obesity co-morbidities
Extension
Potential continuation of monitoring and support for families showing significant progress
What Are the Treatments Tested in This Trial?
Interventions
- Family-Based Treatment for T1D
Find a Clinic Near You
Who Is Running the Clinical Trial?
University at Buffalo
Lead Sponsor
State University of New York at Buffalo
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator